Introduction
Nutritional and immunological requirements for growth and development of preterm infants are under continuous investigation [4, 6] . There are many reports stating that milk produced by mothers of term infants provides all the necessary nutritional requirements. Recent reports have suggested that preterm infants may benefit from their mother's milk for their nutritional and immunological adaptation. Milk obtained from mothers of preterm neonates has increased contents of protein, fat, sodium and chloride, and lower concentration of lactose when compared with that of mothers of full term babies [1, 3, 8, 9] . The composition of saturated and unsaturated fatty acids is the same [14] . Besides its nutritional components, human milk contains many factors with bacteriostatic effects on the growth of many bacterial species including E. Coli [7, 10, 15] . Secretory IgA plays a major role in the protection of neonates from infection. In a longitudinal study of the effect of prematurity on the development of several components of the immunological system GOLDMAN [5] found that the concentration of lactoferrin and lysozyme were greater in preterm than in term infants. The secretory IgA was the predominant form in preterm mother's milk. It is common in many obstetrical clinics to treat threatened premature labor by inhibiting uterine contractility with a betamimetic drug along with the administration of a glucocorticoid agent to prevent the respiratory distress syndrome in the neonate [11] . The aim of this study has been to find if these drugs given to mothers who delivered preterm infants had any influence on the secretory IgA concentration of maternal milk.
Material and methods
Milk samples from three groups of mothers have been studied. Group I: 11 mothers who delivered preterm neonates between 27 and 36 weeks of gestation by Walter de Gruyter Co. Berlin · New York and not receiving any medication prior to delivery. Group II: 10 mothers whose delivery occurred between 27 and 36 weeks gestational age and who received Fenoterol between 1 and4Mg/minute I.V. or 20 mg daily orally, during 48 hours before delivery and a glucocorticoid agent (at least two doses of betametasone, 12 mg I.M., 48 and 24 hours before delivery). Group III: 11 mothers giving birth at between 38 and 40 weeks of gestational age were considered as control group. All the mothers aged between 18 and 32 years, were in apparently good health, good nutritional state and had no local inflammation of the breast. The ratio of nulliparous and multiparous women as well as the ratio of boys and girls in the offspring of each group were approximately equal. All mothers had ruptured membranes twelve or less hours before delivery. Gestational age was determined from the last menstrual period and by physical and neurological examination of the newborn. When the difference was greater than 15 days, the mothers were not admitted to the study. The milk samples were collected with the following method: At 8 a.m. mechanical emptying of both breasts was performed and the milk was discarded. After three hours (11 a.m.) the same procedure was used to empty both breasts. This was done to establish a definite period of time and to avoid possible changes in concentration which may occur during the night. The milk from both breasts was mixed, the volume measured and an aliquot was removed and stored at -20°C. The secretory IgA determination was performed between 20 and 30 days after obtaining the samples. In each mother, the milk sample was obtained at three periods after delivery. The first one was collected between the 4th and 5th day, the second between the 8th and 10th day, and the last between the 14th and 15th day. Milk was not studied in the first three days after delivery, because mothers of preterm infants have little milk secretion at this time due to the fact that these infants are frequently nourished parenterally at this moment.
The quantitative determination of secretory IgA was carried out by the radial immunodiffusion technique of MANCINI et al. [13] using a specific antibody against the secretory piece (Bering Institute). The secretory IgA used for the reference standard was isolated and purified from colostrum and its protein concentration measured by microbiuret. All samples assayed, including the standard, were done in duplicate. A linear regression analysis was performed (r 2 = 0.94). The analysis of variance was used to assess the concentration within the groups in every period studied. The STUDENT'S paired test was used for the analysis of the evolution of the secretoy IgA concentration in each group at the different study periods.
Results
The gestational age in the preterm groups is shown in Tab. I. There was no significant difference between both groups, with and without drugs. Tab. II shows the concentration in the secretory IgA in the three groups. The secretory IgA concentration in mothers who delivered at term was not significantly different, at any of the three periods, from mothers delivering preterm infants having or having not received glucocorticoid and betamimetic therapy (Fig. 1) . The concentration dropped abruptly at the beginning in the three groups and then remained unchanged. The differences were really important between the first and the second period (p < Ö.05) but there was no significant difference between the second and third periods (Fig. 2 
Discussion
The secretory IgA is the most concentrated immunoglobulin in human milk and provides it with anti-infection properties against a great variety of germs. Owing to its physical and chemical structure it is not affected by either digestive juices or pH changes. The quantification of milk secretory IgA, is a difficult technical problem and many kinds of methods have been used. The previous mentioned values in human milk are expressed in different ways. These have been reported in arbitrary units, mg/g protein [15] , g/1 [10, 12] and mg/ml [5] . Our values are expressed in g/1, and they are quite similar to those reported by HANSON et al. [10] and GOLDMAN et al. [5] . We have not found differences in concentration in mothers with a full term delivery when compared with those who had a preterm delivery, having or having not received drugs. The same was found for colostrum, transitional and mature milk. This is a very important fact since drugs administered for the acceleration of pulmonary maturity and inhibition of uterine contractility in preterm labor would not produce modification in the secretory IgA concentration in maternal milk. This latter fact has not yet been pointed out regarding concentrations in preterm mother's milk.
Other authors, such as GROSS et al. [7] and LUCAS et al. [12] have found that the IgA secretory concentration is greater in preterm mothers. We have not been able to confirm this in our study. These authors do not mention whether the mothers were given any kind of medication.
According to the present study, it may be stated that glucocorticoid and betamimetic administration has no effects on the secretory IgA concentration in maternal milk. Supporting the statements of other authors [1, 2, requirements could be met with milk from their 3, 5, 7, 8, 9, 12, 14], we may conclude that the own mothers. It therefore would be unnecessary preterm infant's nutritional and immunological to give formula or bank milk.
Summary
A prospective study was performed to find the possible difference in secretory IgA concentration in milk of mothers with term pregnancy labors and those delivering at earlier gestational ages. Since tocolytic drugs and/or glucocorticoid agents are usually given in cases of threatened premature labor, the pre-term group was divided into mothers with or without medication. Thirty two mothers were distributed in three groups: Group I, mothers with preterm labors without any medication; Group II, preterm labors with previous treat-N ment with betamimetics and glucocorticoids; Group III, term labors (see Tab. I). In each of the three groups, three periods were studied: colostral (4 to 5 days postpartum), transitional (8 to 10 days), and mature (14 to 15 days). All mothers were healthy, with good nutritional state, without local inflammation and membranes had been ruptured 12 hours or less before labor. There was no significant difference in the proportion of primiparas and multiparas in both groups. The gestational age was evaluated by amenorrhea and neonatal examination. In all mothers milk was extracted with a vacuum pump to empty the mammary gland. The determinations were made using a specific antibody against the secretory component. The concentration of free secretory component in these milks was practically insignificant. No differences were found in the concentration of secretory IgA among the three groups (Tab. II, Fig. 1 ) in the periods that were studied, colostral, transitional or mature. The farther away from labor that milk extraction was made, in the periods considered in our study, there is a progressive decrease in the concentration of secretory IgA (Fig. 2) . No evidence has been found showing that medication given to the mother during the hours before delivery affects the concentration of secretory IgA in milk. This knowledge, together with other information previously described regarding composition of preterm mother's milk, supports the statement that preterm neonates may be fed with their own mother's milk. On n'a pas trouve de difference dans la concentration des IgA secretoires entre les 3 groupes (Tab. II, Fig. 1 ), au cours des 3 periodes etudiees, colostrale, transitionnelle et mature. Aussi longtemps que Fon a poursuivi les prelevements de lait apres Faccouchement, il y a eu dans les periodes de notre etude une diminution progressive de la concentration des IgA secretoires (Fig. 2) Despite more than a century of ever-increasing scientific interest and research, anorexia nervosa -the pathological pursuit of thinness -still presents a challenge to clinicians throughout the world. It has become practically impossible to keep in touch with the constant proliferation of scientific literature on this subject. Moreover, the clinician (the general practitioner, the psychiatrist or the psychologist) needs, first and foremost, practical guidelines for his everyday therapeutic work with these patients.
Therefore, two experienced clinicians, who are daily involved in research and treatment of large numbers of anorexia nervosa patients, decided to write the first book dealing extensively with the many practical issues one is faced with when investigating and treating anorectic patients of all ages and in all stages of their illness. No single treatment modality, psychotherapeutic, pharmacologic or nutritional, has provided the final solution for the management of this intriguing syndrome. Hence, the therapeutic approach described in this book is characterized as an eclectic, broad spectrum or multimodal treatment in which strategies and interventions from different therapeutic models have been integrated. 
